These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3040797)

  • 1. Normal suppressive T cell function of Epstein-Barr virus-induced B cell activation in Graves' disease.
    Kahan A; Lefloch JP; Charreire J
    J Clin Endocrinol Metab; 1987 Sep; 65(3):555-60. PubMed ID: 3040797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal suppressive T cell function of Epstein-Barr virus induced B cell activation in type 1 (insulin dependent) diabetes mellitus.
    Kahan A; LeFloch JP; Charreire J
    Autoimmunity; 1990; 5(4):257-64. PubMed ID: 1966582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive T cell function of Epstein-Barr virus induced B cell activation in active Behçet's disease.
    Hamzaoui K; Kahan A; Hamza M; Ayed K
    Clin Exp Rheumatol; 1991; 9(2):131-5. PubMed ID: 1647911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
    Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
    Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
    Tsokos GC; Magrath IT; Balow JE
    J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus Lytic Reactivation Activates B Cells Polyclonally and Induces Activation-Induced Cytidine Deaminase Expression: A Mechanism Underlying Autoimmunity and Its Contribution to Graves' Disease.
    Nagata K; Kumata K; Nakayama Y; Satoh Y; Sugihara H; Hara S; Matsushita M; Kuwamoto S; Kato M; Murakami I; Hayashi K
    Viral Immunol; 2017 Apr; 30(3):240-249. PubMed ID: 28333576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis.
    Tosato G; Steinberg AD; Blaese RM
    N Engl J Med; 1981 Nov; 305(21):1238-43. PubMed ID: 6270556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G; Magrath IT; Blaese RM
    J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of persistent Epstein-Barr virus (EBV) causes secretion of thyrotropin receptor antibodies (TRAbs) in EBV-infected B lymphocytes with TRAbs on their surface.
    Nagata K; Nakayama Y; Higaki K; Ochi M; Kanai K; Matsushita M; Kuwamoto S; Kato M; Murakami I; Iwasaki T; Nanba E; Kimura H; Hayashi K
    Autoimmunity; 2015; 48(5):328-35. PubMed ID: 25759125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid stimulating immunoglobulin (TSI) synthesis by pokeweed mitogen (PWM) stimulated peripheral blood lymphocytes (PBL) from Graves' disease (GD) patients.
    Pautard B; Rémy JJ; Charreire J
    Clin Exp Immunol; 1986 Nov; 66(2):435-42. PubMed ID: 2880683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The regulation of B-lymphocyte activity by the Epstein-Barr virus in ankylosing spondylarthritis].
    Peĭcheva V; Kan A; Amor B
    Vutr Boles; 1990; 29(5):88-91. PubMed ID: 1964317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease.
    Mao C; Wang S; Xiao Y; Xu J; Jiang Q; Jin M; Jiang X; Guo H; Ning G; Zhang Y
    J Immunol; 2011 Apr; 186(8):4734-43. PubMed ID: 21398613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
    Yokoyama N; Izumi M; Katamine S; Nagataki S
    J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
    Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
    J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis.
    Kahan A; Kahan A; Menkes CJ; Amor B
    Ann Rheum Dis; 1986 Jul; 45(7):553-60. PubMed ID: 3017245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.
    Charreire J; Karsenty G; Bouchard P; Schaison G
    Clin Exp Immunol; 1984 Sep; 57(3):633-8. PubMed ID: 6147216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol Affects Epstein-Barr Virus Reactivation-Induced Thyrotropin Receptor Antibody and Immunoglobulin Production in Graves' Disease Patients and Healthy Controls.
    Hara S; Nagata K; Kumata K; Matsushita M; Kuwamoto S; Kato M; Hayashi K
    Viral Immunol; 2018 Sep; 31(7):486-491. PubMed ID: 30133352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell sensitization to autologous thyroid cells and normal non-specific suppressor T-cell function in Graves' disease.
    Davies TF; Bermas B; Platzer M; Roman SH
    Clin Endocrinol (Oxf); 1985 Feb; 22(2):155-67. PubMed ID: 3157510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
    Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
    J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
    Chan JY; Walfish PG
    J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.